Keywords: b-ms, otsuka, submit, aripiprazole, bristol-myers, squibb, japan
B-MS and Otsuka submit aripiprazole
Article | 08 November 2001
Bristol-Myers Squibb and Japan's Otsuka Pharmaceuticals have filed aNew Drug Application with the US Food and Drug Administration for aripiprazole ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Bristol-Myers' data on Yervoy and nivolumab causes a stir
- Boehringer Ingelheim transitions to propellant-free Combivent Respimat; names new BMD member
- Encouraging results with Sangamo's SB-728-T in HIV treatment
- Sanofi prepares for regulatory filing of MF candidate on positive JAKARTA study results
- New study shows UCB's Neupro reduces NSBP in RLS patient
